Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry®, is the largest owner and pre-eminent first-in-class real estate investment trust focused principally on science-driven cluster formation. Alexandria is the leading provider of real estate to the life science industry, and has an outstanding 11 year track record as a NYSE listed company with an approximate $5.2 billion total market capitalization (as of December 31, 2008).
| Company | Date | Round | Size | Participants |
| Oncofactor Corporation | 8/11 | Series A | $2.1M | 6 |
| Acylin Therapeutics | 1/11 | Series A | $4.4M | 4 |
| Mirina | 4/10 | Series A | $3.9M | 5 |
| Theraclone Sciences | 3/10 | Unattributed | $1.5M | 6 |
| Metabolon | 12/09 | Series C | $6M | 7 |
| Cambrios Technologies | 11/09 | Series D | $14.5M | 14 |
| BrainCells | 4/08 | Series B | $20M | 2 |
| Cerulean Pharma | 1/08 | Series B | $8.1M | 5 |
| Allozyne | 10/07 | Series B | $30M | 5 |
| nanosys | 11/05 | Series D | $41.5M | 16 |
